Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Pilot trial of gabapentin for the treatment of benzodiazepine abuse or dependence in methadone maintenance patients.

Mariani JJ, Malcolm RJ, Mamczur AK, Choi JC, Brady R, Nunes E, Levin FR.

Am J Drug Alcohol Abuse. 2016 May;42(3):333-40. doi: 10.3109/00952990.2015.1125493.

PMID:
26962719
2.

Effect of Primidone on Dentate Nucleus γ-Aminobutyric Acid Concentration in Patients With Essential Tremor.

Louis ED, Hernandez N, Dyke JP, Ma R, Dydak U.

Clin Neuropharmacol. 2016 Jan-Feb;39(1):24-8. doi: 10.1097/WNF.0000000000000127.

PMID:
26757316
3.

Neurotransmitters as food supplements: the effects of GABA on brain and behavior.

Boonstra E, de Kleijn R, Colzato LS, Alkemade A, Forstmann BU, Nieuwenhuis S.

Front Psychol. 2015 Oct 6;6:1520. doi: 10.3389/fpsyg.2015.01520. Review.

4.

Separate and combined effects of gabapentin and [INCREMENT]9-tetrahydrocannabinol in humans discriminating [INCREMENT]9-tetrahydrocannabinol.

Lile JA, Wesley MJ, Kelly TH, Hays LR.

Behav Pharmacol. 2016 Apr;27(2-3 Spec Issue):215-24. doi: 10.1097/FBP.0000000000000187.

PMID:
26313650
5.

γ-Aminobutyric acid (GABA) administration improves action selection processes: a randomised controlled trial.

Steenbergen L, Sellaro R, Stock AK, Beste C, Colzato LS.

Sci Rep. 2015 Jul 31;5:12770. doi: 10.1038/srep12770.

6.

An update of the classical and novel methods used for measuring fast neurotransmitters during normal and brain altered function.

Cifuentes Castro VH, López Valenzuela CL, Salazar Sánchez JC, Peña KP, López Pérez SJ, Ibarra JO, Villagrán AM.

Curr Neuropharmacol. 2014 Dec;12(6):490-508. doi: 10.2174/1570159X13666141223223657.

7.

Allosteric Modulation of GABAA Receptors by an Anilino Enaminone in an Olfactory Center of the Mouse Brain.

Heinbockel T, Wang ZJ, Jackson-Ayotunde PL.

Pharmaceuticals (Basel). 2014 Dec 17;7(12):1069-90. doi: 10.3390/ph7121069. Review.

8.

GABAergic contributions to alcohol responsivity during adolescence: insights from preclinical and clinical studies.

Silveri MM.

Pharmacol Ther. 2014 Aug;143(2):197-216. doi: 10.1016/j.pharmthera.2014.03.001. Review.

9.

The impact of gabapentin administration on brain GABA and glutamate concentrations: a 7T ¹H-MRS study.

Cai K, Nanga RP, Lamprou L, Schinstine C, Elliott M, Hariharan H, Reddy R, Epperson CN.

Neuropsychopharmacology. 2012 Dec;37(13):2764-71. doi: 10.1038/npp.2012.142.

10.

Effects of pregabalin on smoking behavior, withdrawal symptoms, and cognitive performance in smokers.

Herman AI, Waters AJ, McKee SA, Sofuoglu M.

Psychopharmacology (Berl). 2012 Apr;220(3):611-7. doi: 10.1007/s00213-011-2507-x.

11.

A substituted anilino enaminone acts as a novel positive allosteric modulator of GABA(A) receptors in the mouse brain.

Wang ZJ, Sun L, Jackson PL, Scott KR, Heinbockel T.

J Pharmacol Exp Ther. 2011 Mar;336(3):916-24. doi: 10.1124/jpet.110.173740.

12.

A2delta ligands gabapentin and pregabalin: future implications in daily clinical practice.

Tzellos TG, Papazisis G, Toulis KA, Sardeli Ch, Kouvelas D.

Hippokratia. 2010 Apr;14(2):71-5.

13.

New Horizons in the development of antiepileptic drugs: Innovative strategies.

Löscher W, Schmidt D.

Epilepsy Res. 2006 Jun;69(3):183-272.

14.

Neuroimaging of epilepsy: therapeutic implications.

Kuzniecky RI.

NeuroRx. 2005 Apr;2(2):384-93. Review.

Items per page

Supplemental Content

Support Center